The Market for Pediatric Drugs In India Is Expected to cross INR 960 Billion in the Future: Ken Research India pediatric drugs and vaccine market has witnessed tremendous growth in the last five years largely due to high number of annual births recorded at around 25 million, launch of generic formulations of several pediatric drugs including flavored TB drugs, inclusion of several vaccines in the national immunization schedule of the country and inclining coverage… Read More »
India Pediatric Drugs And Vaccines Market Future Outlook To 2021: Ken Research How the Pediatric Drugs and Vaccines Market is Positioned in India? India, a home of the largest pediatric population of the world and also has the highest number of annual child births in the world. However, almost 80-90% of the drugs used in children presently have never been studied for their efficacy in pediatric population.… Read More »
India pediatric drugs and vaccines market has been largely driven by the launch of new drug categories such as Anti-TB drugs and improved healthcare access: Ken Research India’s emergence as a global hub of generic medicines and vaccine supplier has contributed highly towards the growth of the pediatric drugs and vaccines market. The pediatric market for drugs and vaccines has increased in terms of value from FY’2011 to FY’2016 at a CAGR of 18.1% in between the period. Ken Research announced its… Read More »
